an effective in vivo method of protecting myocardium after infarction. Injectable nanofibers allow precise and sustained delivery of proteins to the myocardium with potential therapeutic benefits.
Recovery of the mitochondrial inner membrane potential (A?,) is a key determinant of postischemic functional recovery of the heart. Previously, we showed that mitochondrial reactive oxygen species (R0S)-induced ROS release causes the collapse or oscillation of A*,, destabilizing the action potential (AP), through a mechanism involving mitochondrial inner membrane anion channels (IMAC) modulated by mitochondrial benzodiazepine receptors (mBzR). Here, we test the hypothesis that spatiotemporal heterogeneity of A?, during ischemia and reperfusion (IR) contributes to abnormal electrical activation and increases vulnerability to arrhythmias in the whole heart. High-resolution optical AP mapping was performed in perfused guinea-pig hearts subjected to 30 min of global ischemia, followed by reperfusion. Typical electrophysiological responses, including progressive AP shortening followed by membrane inexcitablity in ischemia, and ventricular fibrillation (VF) upon reperfusion, were observed in control hearts. These responses were reduced or eliminated by treatment with the mBzR antagonist, 4-chlorodiazepam (4'-CI-DZP), which blocks depolarization of A*,. When applied throughout the IR protocol, 4'-CI-DZP blunted AP shortening and prevented reperfusion arrhythmias. Inhibition of VF was also achieved by bolus infusion of 4'-CI-DZP just before reperfusion. Conversely, treatment with an agonist of the mBzR that promotes A?, depolarization exacerbated IR-induced electrophysiological changes and failed to prevent arrhythmias. The effects of these compounds were consistent with their actions on IMAC and A?, in isolated myocytes during exposure to conditions of high oxidative stress that trigger A?, depolarization in a manner akin to metabolic inhibition during ischemia and reperfusion of the heart. Therefore, the present findings directly link instability of A?, and its effects on the cellular AP to the heterogeneous electrophysiological substrate of the postischemic heart and highlight the mitochondrial membrane as a new therapeutic target for arrhythmia prevention in ischemic heart disease. Despite the use of drug-eluting stents (DES), diabetics continue to have higher rates of restenosis. Delayed reendothelialization (ReEndo) contributes to restenosis after angioplasty and stenting and is not improved by currently available DES. Prior data have shown that bone marrow-derived endothelial progenitor cells (EPCs) contribute to endothelial recovery after arterial injury. We investigated the hypothesis that the EPC contribution to ReEndo may be impaired in diabetes and therefore contribute to delayed ReEndo. Methods and Results-Wire-induced carotid denudation was performed in diabetic mice. ReEndo was significantly reduced in diabetic mice as compared with nondiabetic mice (7053.1% versus 86'2.7% at day 7 after surgery, P<0.05). The EPC contribution to neoendothelium, detected by p-gal staining, was significantly reduced in Tie2/LacZ-bone marrow-transplanted diabetic versus nondiabetic mice (27k4.6 versus 76+9.3/mm2, P <0.05). To investigate the role of gene expression by bone marrow-derived cells, the bone marrow from diabetic and nondiabetic mice was transplanted into nondiabetic mice, revealing that Re-Endo was impaired in the recipients of diabetic bone marrow (43+2.1% versus 64+2.7%, P<O.Ol). To examine the relative roles of denuded artery versus EPCs in the impaired recruitment of EPCs to injured arteries in diabetes, we injected diabetic and nondiabetic EPCs intravenously after arterial injury in diabetic and nondiabetic mice. The recruitment of diabetic EPCs to the neoendothelium was significantly reduced regardless of the diabetic status of the recipient mice. In vitro, diabetic EPCs exhibited decreased migration and adhesion activities. Western blot analyses showed that VEGF and eNOS expressions were significantly reduced in diabetic EPCs. Furthermore, quantitative RT-PCR showed that mRNA expression of thrombospondin-1 (TSP-1) was significantly increased in EPCs under high-glucose conditions, associating with the decreased EPC adhesion activity. Conclusions-ReEndo is impaired by malfunctioning EPCs in diabetes. Diabetic EPCs have phenotypic differences involving TSP-1 upregulation compared with nondiabetic EPCs, revealing potential novel mechanistic insights and therapeutic targets to improve ReEndo and reduce restenosis in diabetes. Altering the sequence of ventricular activation (eg, pacing) induces ventricular electrical remodeling (VER), leading to T-wave memory (TWM), progression of heart failure, and increased cardiac mortality. Recently, we demonstrated that preferential action potential duration (APD) prolongation in late activated left ventricular (LV) segments is the electrophysiological basis for TWM. However, a major unresolved question is why repolarizing membrane ion channels strongly depend on the direction of propagation. To address this, VER was induced in 6 dogs by pacing anterior LV epicardium for 4 weeks and compared with unpaced controls (n=5). A significant change in T-wave vector angle (1 14220") provided evidence for VER causing TWM. We utilized a novel tech-nique of multisegment transmural optical mapping to record action potentials from transmural wall of anterior, lateral, and posterior LV segments. After VER induced by anterior LV pacing, preferential and marked APD prolongation occurred in late activated posterior segments as compared with control (288228 ms versus 23228 ms, P<O.Ol). VER induced by posterior LV pacing (n=3) caused APD prolongation in late activated anterior segments (28426 ms versus 23021 1 ms, P<O.OOl), indicating that VER is solely dependent on direction of propagation. Tagged magnetic resonance imaging (n=3) revealed preferential 2-fold increase (P <0.05) of circumferential strain in late activated segments (where VER was greatest). VER did not produce any histological evidence of hypertrophy, fibrosis, or necrosis. Although It, has been implicated in VER, in late activated segments where VER was most marked, It, activity did not change. It, was downregulated in early activated segments due to altered gating kinetics, but not reduction in mRNA or protein for Kv4.3 or KChlP2. Conclusions-Preferential APD prolongation of late activated myocardial segments is the electrophysiological basis for T-wave memory. The mechanism responsible for triggering segmental VER was enhanced circumferential strain and not structural remodeling or altered expression of 4,. These data suggest a novel mechanical-electrical feedback mechanism that induces potentially deleterious electrical heterogeneities in the heart.
EPC TSP-1 Mediates Diabetes-Induced Delay in Reendothelialization After Arterial Injury

Segmental Strain as Novel Mechanism for Ventricular Electrical Remodeling Underlying T-Wave Memory
Posttranscriptional Gene Silencing of the L-Type Calcium Channel Accessory &Subunit Suppresses Cardiac Hypertrophy Response In Vitro and In Vivo
Eugenio Cingolani, Genaro A. Ramirez Correa, Eddy Kizana, Hee Cheol Cho, Michelle K. Leppo, Eduardo Marban, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, M d Although calcium signaling pathways mediate the development of left ventricular hypertrophy (LVH), the clinical use of calcium channel blockers is limited in part by side effects due to blockade of noncardiac channels. Also, whereas the function of the L-type calcium channel p-subunit (LTCCp) has been widely studied in heterologous expression systems, less is known about the role of this molecule in cardiac cells. We studied the effects of genetic suppression of the P-subunit in models of cardiac hypertrophy. A short hairpin RNA (shRNA) against the LTCCp was incorporated into a lentiviral vector (PPT.CG.Hl .p2). A scrambled nonsilencing shRNA sequence was used as a control (PPT.CG.Hl.NS). To test gene knockdown efficacy, HEK293 cells were cotransfected with p,-GFP fusion and shRNA vector plasmids. Flow cytometric analysis showed that &-shRNA reduced p2-GFP mean fluorescence intensity by 645727.5% relative to control (RO.01). The functional effects of LTCCp knockdown were assessed on neonatal rat cardiomyocytes (NRCMs). Calcium currents were suppressed in patch-clamp experiments (P <0.05), and calcium transient amplitude, assessed 72 hours after transduction, was reduced by 34% in PPT.CG.Hl .p2transduced cells as compared with nonsilencing controls (F/Fo=13.0520.55 versus F/Fo=8.54-C0.61, fYO.01). Similarly, [3H]leucine incorporation was attenuated in PPT.CG.Hl .p,-transduced cells as compared with nonsilencing controls (99.321 3% of control versus 173.6-C 18% of control, P <0.05) in a phenylephrine (PE)induced NRCM hypertrophy model. In vivo gene transfer of 1 x 10' transducing unitdheart by aorto/pulmonary clamping and LV cavity injection reduced the hypertrophic response in an aortic banded rat model of LVH. LV wall thickness (2.0920.09 mm versus 2.9620.13 mm, PcO.05) and heart weight/body weight ratios (4.6720.1 1 versus 56920.28, K 0 . 0 5 ) were reduced in PPT.CG.Hl .p,-injected rats at 1 month after transduction. Remarkably, fractional shortening was comparable between groups (6426% versus 61 ?3%, P =NS). These findings indicate that knockdown of LTCCp is capable of attenuating the hypertrophic response both in vitro and in vivo without compromising systolic performance. Suppression of the LTCCp may represent a novel and useful therapeutic target in LVH. Background-Phosphodiesterase type 5 (PDE5) is an enzyme that metabolizes cyclic guanosine monophosphate (cGMP), thereby modulating relaxation and growth inhibition of vascular smooth muscle cells by cGMP, including those in the lung. Recently, this pathway has been targeted for use in patients with pulmonary arterial hypertension. Methods-Samples from patients undergoing lung transplantation for idiopathic pulmonary hypertension (IPAH) and scleroderma-associated pulmonary hypertension (SScPAH) were studied in both arteriolar segments and in an isolated whole-lobar vascular preparation under constant-flow conditions. Flowmediated and agonist-induced vasodilator responses were compared with and without acute and chronic treatment with selective PDE5 inhibitors. Results-Baseline tone was higher and agonist-induced and flowmediated vasorelaxant responses in human lung were markedly reduced in IPAH and SScPAH when compared with donor control arterioles. These aberrancies were associated with markedly higher PDE5 mRNA, protein expression, and activity when compared with donor arterioles. Treatment with prolonged exposure to PDE5 inhibitors (24 hours under culture conditions) resulted in a partial restoration of agonist-and flow-mediated vasorelaxation and was associated with a modulation of the RhoNrho kinase protein expression and activity. Conclusion-PDE5 protein and activity are higher in the lungs of patients with IPAH and SSc and reciprocally regulate the activity of endothelium-dependent and vasodilator responses in the lung. Moreover, treatment with sildenafil
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Pulmonary Hypertension Is Associated With Increased Expression and Activity of
